Cardinal Health, Inc.

Cardinal Health, Inc.

CAHยทNYSE

$195.85

+0.50%
HealthcareMedical - Distribution

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

At a Glance

Live Snapshot
Market Cap$45.87B
EPS6.4800
P/E Ratio30.22
Earnings Date08/11/2026
11.37%
Return on Invested Capital
29%
3Y-362.0%
5Y-149.0%
10Y+10.0%
-56.13%
Return on Equity
112%
3Y-142.0%
5Y-73.0%
10Y-358.0%
2.94%
Return on Assets
56%
3Y-237.0%
5Y-132.0%
10Y-30.0%
Cardinal Health, Inc.

Cardinal Health, Inc. Management Team

CAH ยท NYSE
MJ

Mr. Jason M. Hollar

Chief Executive Officer & Director

Compensation

$5,544,754

Born 1973(Age 53)
male
MS

Mr. Stephen M. Mason

Chief Executive Officer of GMPD segment

Compensation

$1,387,127

Born 1971(Age 55)
male
MS

Mr. Stephen M. Mason

Chief Executive Officer of Medical Segment

Compensation

$1,362,141

Born 1972(Age 54)
male
MD

Ms. Deborah L. Weitzman

Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment

Compensation

$1,736,640

Born 1965(Age 61)
female
MA

Mr. Aaron E. Alt J.D.

Chief Financial Officer

Compensation

$2,232,222

Born 1972(Age 54)
male
MO

Ms. Ola M. Snow

Chief Human Resources Officer

Born 1968(Age 58)
female
MJ

Ms. Jessica L. Mayer

Chief Legal & Compliance Officer

Compensation

$1,722,409

Born 1969(Age 57)
female
MC

Mr. Craig Cowman

Executive Vice President of Biopharma Solutions & Strategic Sourcing

male
MP

Ms. Patricia M. English CPA

Senior Vice President

Compensation

$451,344

Born 1980(Age 46)
female
MM

Ms. Mary C. Scherer

Senior Vice President & Chief Accounting Officer

female
MS

Matt Sims

Vice President of Investor Relations

cah

Cardinal Health, Inc. Insider Positioning

CAH ยท NYSE

During the last 12 months, insiders have sold $13.72M worth of CAH shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

6.4K

1.47M

Net Activity

-1.5M

-$1.47M

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

81.7K

12.25M

Net Activity

-12.3M

-$12.25M

Top Buyers

No buying activity

Top Sellers

1
HJM

Hollar Jason M.

Officer: Chief Executive Officer

29.3K sharesโ€ข2 transactions

$4.40M

2
WD

Weitzman Deborah

Officer: Ceo, Pss Segment

21.4K sharesโ€ข1 transactions

$3.22M

3
AAE

Alt Aaron E

Officer: Chief Financial Officer

16.1K sharesโ€ข2 transactions

$2.58M

4
SMC

Scherer Mary C.

Officer: Chief Accounting Officer

6.8K sharesโ€ข1 transactions

$1.01M

5
HPH

Hall Patricia Hemingway

Director

4.0K sharesโ€ข1 transactions

$919K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $13.72M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

SEC Filings

CAH - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2025

N/A

September 16, 2025
November 05, 2025
2025
DEF 14A

DEF 14A 2024

N/A

September 16, 2024
November 06, 2024
2024
DEF 14A

DEF 14A 2023

N/A

September 27, 2023
November 15, 2023
2023
DEF 14A

DEF 14A 2022

N/A

September 28, 2022
November 09, 2022
2022
DEF 14A

DEF 14A 2021

N/A

September 23, 2021
November 05, 2021
2021
DEF 14A

DEF 14A 2020

N/A

September 23, 2020
November 04, 2020
2020
DEF 14A

DEF 14A 2019

N/A

September 20, 2019
November 06, 2019
2019
DEF 14A

DEF 14A 2018

N/A

September 26, 2018
September 26, 2018
2018
DEF 14A

DEF 14A 2017

N/A

September 21, 2017
November 08, 2017
2017
DEF 14A

DEF 14A 2016

N/A

September 16, 2016
November 03, 2016
2016
Showing 1 to 10 of 33 filings